Editoria e Media
Global Pharma, Biotech and Diagnostics Option and Evaluation Partnership Terms and Agreements Analysis 2010-2016 - Research and Markets
This report focuses on option and evaluation agreements and clauses within broader agreements between big pharma-big pharma, big pharma - smaller company, and smaller company-smaller company, providing a detailed insight into all such deals.
The report provides a detailed understanding and analysis of how and why companies enter option and evaluation deals. The majority of deals are multicomponent whereby the licensor retains either a option and evaluation right to the resultant product of the research collaboration. There are also numerous pure option and evaluation deals whereby the products originator takes on a partner in order to advance the product or compound to a point where the licensee might seek to proceed to a licensing deal.
This report contains a comprehensive listing of all option and evaluation deals announced since 2010 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual option and evaluation contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Executive Summary
1 Introduction
2 Trends in option and evaluation dealmaking
3 Overview of option and evaluation deal structure
4 Leading option and evaluation deals
5 Top 50 most active option and evaluation dealmakers
6 Option and evaluation contracts directory
For more information about this report visit http://www.researchandmarkets.com/research/wdzc38/global_option_and
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood , Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716